糖尿病、高血压与心血管疾病：临床见解、机制与药物治疗
Diabetes, Hypertension and Cardiovascular Disease: Clinical Insights, Mechanisms and Pharmacotherapies.
作者信息
Hung Ming-Jui
机构信息
Section of Cardiovascular Imaging, Division of Cardiology, Department of Internal Medicine, Chang Gung Memorial Hospital at Keelung, Keelung 20401, Taiwan.
College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan.
出版信息
Medicina (Kaunas). 2024 Mar 30;60(4):566. doi: 10.3390/medicina60040566.
Abstract
Cardiovascular disease (CVD) is a serious issue demanding world attention, not only because of its role in increased mortality, but also in conjunction with the aging population and growing prevalence of other co-morbidities, such as hypertension, diabetes, etc [...].
摘要
心血管疾病（CVD）是一个需要全球关注的严重问题，不仅因为它在增加死亡率方面所起的作用，还因为随着人口老龄化以及其他合并症（如高血压、糖尿病等）的患病率不断上升[……]。
相似文献
1
Diabetes, Hypertension and Cardiovascular Disease: Clinical Insights, Mechanisms and Pharmacotherapies.
Medicina (Kaunas). 2024 Mar 30;60(4):566. doi: 10.3390/medicina60040566.
2
Antiplatelet activity of drugs used in hypertension, dyslipidemia and diabetes: Additional benefit in cardiovascular diseases prevention.
Vascul Pharmacol. 2017 Apr;91:10-17. doi: 10.1016/j.vph.2017.03.004. Epub 2017 Mar 22.
3
Risk factors for and management of post-transplantation cardiovascular disease.
BioDrugs. 2001;15(4):261-78. doi: 10.2165/00063030-200115040-00006.
4
Brief comments on the issue of cardiovascular risk in diabetic patients.
Am J Hypertens. 2004 Jul;17(7):640. doi: 10.1016/j.amjhyper.2004.03.677.
5
New drugs and clinical trials in diabetes and hypertension.
Exp Clin Endocrinol Diabetes. 1997;105 Suppl 2:64-9. doi: 10.1055/s-0029-1211801.
6
Hypertension: Current trends and future perspectives.
Br J Clin Pharmacol. 2021 Oct;87(10):3721-3736. doi: 10.1111/bcp.14825. Epub 2021 May 3.
7
Arresting cardiovascular disease progression. Early treatment may counteract high risk.
Postgrad Med. 2004 Aug;116(2):45-8. doi: 10.3810/pgm.2004.08.1570.
8
Other drug treatments: the evidence.
Proc Nutr Soc. 2000 Aug;59(3):425-6. doi: 10.1017/s0029665100000525.
9
Cardiovascular risk factors among high-risk individuals attending the general practice at king Abdulaziz University hospital: a cross-sectional study.
BMC Cardiovasc Disord. 2019 Nov 27;19(1):268. doi: 10.1186/s12872-019-1261-6.
10
Trends in cardiovascular risk factors among U.S. men and women with and without diabetes, 1988-2014.
BMC Public Health. 2017 Nov 22;17(1):893. doi: 10.1186/s12889-017-4921-4.
引用本文的文献
1
The predictive significance of the triglyceride-glucose index in forecasting adverse cardiovascular events among type 2 diabetes mellitus patients with co-existing hyperuricemia: a retrospective cohort study.
Cardiovasc Diabetol. 2025 May 21;24(1):218. doi: 10.1186/s12933-025-02783-9.
2
Population and Co-Occurrence Characteristics of Diagnoses and Comorbidities in Coronary Artery Disease Patients: A Case Study from a Hospital in Guangxi, China.
Bioengineering (Basel). 2024 Dec 18;11(12):1284. doi: 10.3390/bioengineering11121284.
本文引用的文献
1
A Review and Meta-Analysis of the Safety and Efficacy of Using Glucagon-like Peptide-1 Receptor Agonists.
Medicina (Kaunas). 2024 Feb 21;60(3):357. doi: 10.3390/medicina60030357.
2
Hypoglycemic Effect of an Herbal Decoction (Modified Gangsimtang) in a Patient with Severe Type 2 Diabetes Mellitus Refusing Oral Anti-Diabetic Medication: A Case Report.
Medicina (Kaunas). 2023 Oct 30;59(11):1919. doi: 10.3390/medicina59111919.
3
Effectiveness and Safety of Fufang Danshen Dripping Pill (Cardiotonic Pill) on Blood Viscosity and Hemorheological Factors for Cardiovascular Event Prevention in Patients with Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis.
Medicina (Kaunas). 2023 Sep 27;59(10):1730. doi: 10.3390/medicina59101730.
4
The Role Played by Novel Inflammatory Markers in Assessment of Peripheral Artery Disease.
Medicina (Kaunas). 2023 Aug 28;59(9):1557. doi: 10.3390/medicina59091557.
5
Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality.
N Engl J Med. 2023 Oct 5;389(14):1273-1285. doi: 10.1056/NEJMoa2206916. Epub 2023 Aug 26.
6
Effectiveness and Safety of Dabigatran Reversal with Idarucizumab in the Taiwanese Population: A Comparison Based on Eligibility for Inclusion in Clinical Trials.
Medicina (Kaunas). 2023 May 4;59(5):881. doi: 10.3390/medicina59050881.
7
Coronary Artery Spasm-Related Heart Failure Syndrome: Literature Review.
Int J Mol Sci. 2023 Apr 19;24(8):7530. doi: 10.3390/ijms24087530.
8
Associations of Three-Dimensional Anthropometric Body Surface Scanning Measurements and Coronary Artery Disease.
Medicina (Kaunas). 2023 Mar 15;59(3):570. doi: 10.3390/medicina59030570.
9
Urinary microRNA in Diabetic Kidney Disease: A Literature Review.
Medicina (Kaunas). 2023 Feb 13;59(2):354. doi: 10.3390/medicina59020354.
10
Optimal Heart Rate Control Improves Long-Term Prognosis of Decompensated Heart Failure with Reduced Ejection Fraction.
Medicina (Kaunas). 2023 Feb 12;59(2):348. doi: 10.3390/medicina59020348.
Zotero 插件